Billionaire Gupta May Acquire U.S. Drug Brands: Corporate India

Updated on

Lupin Ltd., the world’s biggest maker of drugs to treat tuberculosis, plans to acquire brands in the U.S. to reduce its reliance on less profitable generic medicines, President Nilesh Gupta said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.